delivery
Behavioraldelivery either vaginal or by cesarean section
NCT Number: NCT02661867
Objective of this longitudinal observational cohort study was to analyze incidence of pelvic floor dysfunction (PFD) symptoms, including pelvic organ prolapse (POP), urinary incontinence (UI), and fecal incontinence (FI), seven to twelve years after delivery, in two groups of singleton primiparae after vaginal delivery (VD) and cesarean section (CS).
Looking for future studies?
Notify MeFemale
Observational
Pelvic floor disorders (PFD) usually refers to three definable groups of symptoms that include pelvic organ prolapse (POP), urinary incontinence (UI), and fecal incontinence (FI). The prevalence of these conditions increases with age, but in general, PFD affect 20-50 % of women throughout their lives. Thus, PFD are common and have significant societal impact. Another important PFD risk factor is childbearing. Specifically, these disorders are more common among multiparas. Vaginal delivery (VD) has been considered the main contributing factor because of pelvic floor muscle, fascia, and nerves damage.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
delivery either vaginal or by cesarean section
Time frame: seven years after delivery
calculated from validated questionnaire International Consultation on Incontinence Questionnaire Short Form (ICIQ-SF)
Time frame: seven years after delivery
calculated from validated questionnaire Pelvic Organ Prolapse Distress Inventory (POPDI-6)
Time frame: seven years after delivery
calculated from validated questionnaire Wexner Fecal Incontinence Score (WS)
Brno University Hospital
Other
Pelvic Floor Function Evaluation of Singleton Primiparae After Vaginal Delivery and Cesarean Section: Seven to Twelve-Year Long Observational Cohort Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04415710
Constipation, Female Urogenital Diseases
Antalya, Turkey, Turkey (Türkiye)
View Trial DetailsNCT02259712
Digestive System Diseases, Fecal Incontinence
Alcalá de Henares, Madrid, Spain
View Trial DetailsNCT04038099
Cystocele, Female Urogenital Diseases
Dallas, Texas, United States
View Trial DetailsNCT04048356
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Albuquerque, New Mexico, United States
View Trial Details